Getting type 2 diabetes at an early age increases risk for all diabetes complications, including death.
Read More »Randomized Controlled Trials Vs. Effectiveness Of Real-World Use Of GLP-1’s and DPP4 Therapies
Why patients are not seeing results when it comes to adhering to treatment plans.
Read More »A New Diabetes Epidemic: “Nonadherence”
How can health care practitioners play a more prominent role in helping patients to take prescribed medications?
Read More »A Summary of ADA’s New 2018 Standards of Medical Care in Diabetes
Comprehensive recommendations feature notable new recommendations for people with cardiovascular disease and diabetes.
Read More »Safety and Efficacy of a New Long-Acting Exenatide Formulation: BYDUREON® BCise™
Once-weekly injectable suspension can provide as much benefit as traditional twice-daily dosing.
Read More »Study Finds Moderate Increase in Physical Activity Reduces Glucose, A1c
Benefits of exercise shown to depend on duration, not exercise type
Read More »Awareness of Type 3C Diabetes and Why It Is Misdiagnosed
Diabetes has long been divided into type 1 and type 2. But a third type has entered the mix — and we aren't diagnosing it correctly.
Read More »Insulin Pump Interruptions Reduce Hypoglycemia
Sensor-augmented therapy can diminish hypoglycemia with the low-glucose suspend feature.
Read More »OptiScanner
OptiScanner is the first-of-its-kind bedside blood monitoring platform that provides plasma-based, automated monitoring of ICU patients’ glucose levels. The OptiScanner 5000 directly measures plasma glucose levels using an integrated blood centrifuge and spectrometer to help avoid dangerous glycemic variations and assist clinicians in achieving the right level of glucose control.
Read More »FDA Approves Fast-Acting Mealtime Insulin
A new formulation of Insulin Aspart can offer better glycemic control and may also be given after meals.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.